The Role of MicroRNAs in Kidney Disease

Overview

Journal Noncoding RNA

Date 2018 Jun 5

PMID 29861424

Citations 17

Authors

Sydwell Mukhadi

Rodney Hull

Zukile Mbita

Zodwa Dlamini

Affiliations

Soon will be listed here.

Abstract

MicroRNAs (miRNAs) are short noncoding RNAs that regulate pathophysiological processes that suppress gene expression by binding to messenger RNAs. These biomolecules can be used to study gene regulation and protein expression, which will allow better understanding of many biological processes such as cell cycle progression and apoptosis that control the fate of cells. Several pathways have also been implicated to be involved in kidney diseases such as Transforming Growth Factor-β, Mitogen-Activated Protein Kinase signaling, and Wnt signaling pathways. The discovery of miRNAs has provided new insights into kidney pathologies and may provide new innovative and effective therapeutic strategies. Research has demonstrated the role of miRNAs in a variety of kidney diseases including renal cell carcinoma, diabetic nephropathy, nephritic syndrome, renal fibrosis, lupus nephritis and acute pyelonephritis. MiRNAs are implicated as playing a role in these diseases due to their role in apoptosis, cell proliferation, differentiation and development. As miRNAs have been detected in a stable condition in different biological fluids, they have the potential to be tools to study the pathogenesis of human diseases with a great potential to be used in disease prognosis and diagnosis. The purpose of this review is to examine the role of miRNA in kidney disease.

Citing Articles

MiR-192-5p targets cell cycle regulation in diabetic kidney disease via cyclin-dependent kinase inhibitor 3.

Sahoo B, Mishra D, Tiwari S Noncoding RNA Res. 2024; 11:60-72.

PMID: 39736853 PMC: 11683246. DOI: 10.1016/j.ncrna.2024.11.003.

Complex Pathophysiology of Acute Kidney Injury (AKI) in Aging: Epigenetic Regulation, Matrix Remodeling, and the Healing Effects of HS.

Gupta S, Mandal S, Banerjee K, Almarshood H, Pushpakumar S, Sen U Biomolecules. 2024; 14(9).

PMID: 39334931 PMC: 11429536. DOI: 10.3390/biom14091165.

Plasma miR-150-5p in Renal Transplant Recipients with Acute Antibody-Mediated Rejection.

Zepeda-Quiroz I, Guzman-Martin C, Pena-Pena M, Juarez-Villa J, Soto-Abraham M, Vazquez-Toledo M J Clin Med. 2024; 13(6).

PMID: 38541826 PMC: 10971536. DOI: 10.3390/jcm13061600.

microRNA Expression Profile in Obesity-Induced Kidney Disease Driven by High-Fat Diet in Mice.

Eritja A, Caus M, Belmonte T, de Gonzalo-Calvo D, Garcia-Carrasco A, Martinez A Nutrients. 2024; 16(5).

PMID: 38474819 PMC: 10934936. DOI: 10.3390/nu16050691.

Glycemia-Induced miRNA Changes: A Review.

Al-Mahayni S, Ali M, Khan M, Jamsheer F, Moin A, Butler A Int J Mol Sci. 2023; 24(8).

PMID: 37108651 PMC: 10144997. DOI: 10.3390/ijms24087488.

References

Luo Y, Wang C, Chen X, Zhong T, Cai X, Chen S . Increased serum and urinary microRNAs in children with idiopathic nephrotic syndrome. Clin Chem. 2013; 59(4):658-66. DOI: 10.1373/clinchem.2012.195297. View

Montgomery R, Hullinger T, Semus H, Dickinson B, Seto A, Lynch J . Therapeutic inhibition of miR-208a improves cardiac function and survival during heart failure. Circulation. 2011; 124(14):1537-47. PMC: 3353551. DOI: 10.1161/CIRCULATIONAHA.111.030932. View

Guo H, Ingolia N, Weissman J, Bartel D . Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature. 2010; 466(7308):835-40. PMC: 2990499. DOI: 10.1038/nature09267. View

Fridman E, Dotan Z, Barshack I, David M, Dov A, Tabak S . Accurate molecular classification of renal tumors using microRNA expression. J Mol Diagn. 2010; 12(5):687-96. PMC: 2928434. DOI: 10.2353/jmoldx.2010.090187. View

Zhu S, Pan W, Song X, Liu Y, Shao X, Tang Y . The microRNA miR-23b suppresses IL-17-associated autoimmune inflammation by targeting TAB2, TAB3 and IKK-α. Nat Med. 2012; 18(7):1077-86. DOI: 10.1038/nm.2815. View

Tan Y, Blumenfeld J, Rennert H . Autosomal dominant polycystic kidney disease: genetics, mutations and microRNAs. Biochim Biophys Acta. 2011; 1812(10):1202-12. DOI: 10.1016/j.bbadis.2011.03.002. View

Lee S, Masyuk T, Splinter P, Banales J, Masyuk A, Stroope A . MicroRNA15a modulates expression of the cell-cycle regulator Cdc25A and affects hepatic cystogenesis in a rat model of polycystic kidney disease. J Clin Invest. 2008; 118(11):3714-24. PMC: 2571032. DOI: 10.1172/JCI34922. View

Fiedler J, Gupta S, Thum T . Identification of cardiovascular microRNA targetomes. J Mol Cell Cardiol. 2011; 51(5):674-81. DOI: 10.1016/j.yjmcc.2011.08.017. View

Lu J, Kwan B, Lai F, Tam L, Li E, Chow K . Glomerular and tubulointerstitial miR-638, miR-198 and miR-146a expression in lupus nephritis. Nephrology (Carlton). 2012; 17(4):346-51. DOI: 10.1111/j.1440-1797.2012.01573.x. View

10.

Ohl K, Tenbrock K . Inflammatory cytokines in systemic lupus erythematosus. J Biomed Biotechnol. 2011; 2011:432595. PMC: 3196871. DOI: 10.1155/2011/432595. View

11.

Bottinger E . TGF-beta in renal injury and disease. Semin Nephrol. 2007; 27(3):309-20. DOI: 10.1016/j.semnephrol.2007.02.009. View

12.

Calin G, Sevignani C, Dumitru C, Hyslop T, Noch E, Yendamuri S . Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A. 2004; 101(9):2999-3004. PMC: 365734. DOI: 10.1073/pnas.0307323101. View

13.

Yuan J, Benway C, Bagley J, Iacomini J . MicroRNA-494 promotes cyclosporine-induced nephrotoxicity and epithelial to mesenchymal transition by inhibiting PTEN. Am J Transplant. 2015; 15(6):1682-91. DOI: 10.1111/ajt.13161. View

14.

Wang B, Herman-Edelstein M, Koh P, Burns W, Jandeleit-Dahm K, Watson A . E-cadherin expression is regulated by miR-192/215 by a mechanism that is independent of the profibrotic effects of transforming growth factor-beta. Diabetes. 2010; 59(7):1794-802. PMC: 2889781. DOI: 10.2337/db09-1736. View

15.

Denby L, Ramdas V, McBride M, Wang J, Robinson H, McClure J . miR-21 and miR-214 are consistently modulated during renal injury in rodent models. Am J Pathol. 2011; 179(2):661-72. PMC: 3157202. DOI: 10.1016/j.ajpath.2011.04.021. View

16.

Small E, Olson E . Pervasive roles of microRNAs in cardiovascular biology. Nature. 2011; 469(7330):336-42. PMC: 3073349. DOI: 10.1038/nature09783. View

17.

Ecder T, Schrier R . Hypertension in autosomal-dominant polycystic kidney disease: early occurrence and unique aspects. J Am Soc Nephrol. 2001; 12(1):194-200. DOI: 10.1681/ASN.V121194. View

18.

Frankel L, Christoffersen N, Jacobsen A, Lindow M, Krogh A, Lund A . Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J Biol Chem. 2007; 283(2):1026-33. DOI: 10.1074/jbc.M707224200. View

19.

Fire A, Xu S, Montgomery M, Kostas S, Driver S, Mello C . Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature. 1998; 391(6669):806-11. DOI: 10.1038/35888. View

20.

Ma L, Qu L . The function of microRNAs in renal development and pathophysiology. J Genet Genomics. 2013; 40(4):143-52. DOI: 10.1016/j.jgg.2013.03.002. View